Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
14.77
-0.01 (-0.07%)
At close: Jul 10, 2026, 4:00 PM EDT
14.69
-0.08 (-0.57%)
After-hours: Jul 10, 2026, 4:25 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $201.19 million as of July 10, 2026. Its market cap has increased by 199.40% in one year.
Market Cap
201.19M
Enterprise Value
14.98M
1-Year Change
199.40%
Ranking
Category
Stock Price
$14.77
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $201.19M, a decrease of -17.41%. That is a compound annual growth rate of -2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 201.19M | 213.40% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 213.14M |
| Nkarta | 212.49M |
| Korro Bio | 209.99M |
| Voyager Therapeutics | 207.85M |
| Tonix Pharmaceuticals Holding | 199.74M |
| NervGen Pharma | 199.66M |
| Arcturus Therapeutics Holdings | 198.11M |
| Protalix BioTherapeutics | 196.59M |